The Sodium Iodide Symporter (NIS) As an Imaging Reporter for Gene, Viral, and Cell-based Therapies

Overview

Journal Curr Gene Ther

Publisher Bentham Science Publishers

Specialties Genetics
Pharmacology

Date 2012 Jan 24

PMID 22263922

Citations 74

Authors

Alan R Penheiter

Stephen J Russell

Stephanie K Carlson

Affiliations

Soon will be listed here.

Abstract

Preclinical and clinical tomographic imaging systems increasingly are being utilized for non-invasive imaging of reporter gene products to reveal the distribution of molecular therapeutics within living subjects. Reporter gene and probe combinations can be employed to monitor vectors for gene, viral, and cell-based therapies. There are several reporter systems available; however, those employing radionuclides for positron emission tomography (PET) or singlephoton emission computed tomography (SPECT) offer the highest sensitivity and the greatest promise for deep tissue imaging in humans. Within the category of radionuclide reporters, the thyroidal sodium iodide symporter (NIS) has emerged as one of the most promising for preclinical and translational research. NIS has been incorporated into a remarkable variety of viral and non-viral vectors in which its functionality is conveniently determined by in vitro iodide uptake assays prior to live animal imaging. This review on the NIS reporter will focus on 1) differences between endogenous NIS and heterologously-expressed NIS, 2) qualitative or comparative use of NIS as an imaging reporter in preclinical and translational gene therapy, oncolytic viral therapy, and cell trafficking research, and 3) use of NIS as an absolute quantitative reporter.

Citing Articles

Efficient radiolabeling of mesoporous silica nanoparticles for single-cell PET imaging.

Khan S, Zhong X, Das N, Yu J, Natarajan A, Anders D Eur J Nucl Med Mol Imaging. 2024; .

PMID: 39729092 DOI: 10.1007/s00259-024-07027-8.

A Genetically Engineered Reporter System Designed for H-MRI Allows Quantitative Mapping of Transgene Expression.

Allouche-Arnon H, Montrazi E, Subramani B, Fisler M, Spigel I, Frydman L J Am Chem Soc. 2024; 146(46):31624-31632.

PMID: 39527270 PMC: 11583250. DOI: 10.1021/jacs.4c09572.

Image-Guided Mesenchymal Stem Cell Sodium Iodide Symporter (NIS) Radionuclide Therapy for Glioblastoma.

Shah S, Lucke-Wold B Cancers (Basel). 2024; 16(16).

PMID: 39199662 PMC: 11352884. DOI: 10.3390/cancers16162892.

Long-term engraftment and maturation of autologous iPSC-derived cardiomyocytes in two rhesus macaques.

Lin Y, Sato N, Hong S, Nakamura K, Ferrante E, Yu Z Cell Stem Cell. 2024; 31(7):974-988.e5.

PMID: 38843830 PMC: 11227404. DOI: 10.1016/j.stem.2024.05.005.

Imaging CAR-NK cells targeted to HER2 ovarian cancer with human sodium-iodide symporter-based positron emission tomography.

Shalaby N, Xia Y, Kelly J, Sanchez-Pupo R, Martinez F, Fox M Eur J Nucl Med Mol Imaging. 2024; 51(11):3176-3190.

PMID: 38722382 PMC: 11368970. DOI: 10.1007/s00259-024-06722-w.

References

Chen C, Chang P, Changlai S, Pan L . Effective half life of iodine for five thyroidectomy patients using an in vivo gamma camera approach. J Radiat Res. 2007; 48(6):485-93. DOI: 10.1269/jrr.07031. View

Ogawa O, Umegaki H, Ishiwata K, Asai Y, Ikari H, Oda K . In vivo imaging of adenovirus-mediated over-expression of dopamine D2 receptors in rat striatum by positron emission tomography. Neuroreport. 2000; 11(4):743-8. DOI: 10.1097/00001756-200003200-00018. View

Forrer F, Valkema R, Bernard B, Schramm N, Hoppin J, Rolleman E . In vivo radionuclide uptake quantification using a multi-pinhole SPECT system to predict renal function in small animals. Eur J Nucl Med Mol Imaging. 2006; 33(10):1214-7. DOI: 10.1007/s00259-006-0178-3. View

Franc B, Acton P, Mari C, Hasegawa B . Small-animal SPECT and SPECT/CT: important tools for preclinical investigation. J Nucl Med. 2008; 49(10):1651-63. DOI: 10.2967/jnumed.108.055442. View

Groot-Wassink T, Aboagye E, Wang Y, Lemoine N, Reader A, Vassaux G . Quantitative imaging of Na/I symporter transgene expression using positron emission tomography in the living animal. Mol Ther. 2004; 9(3):436-42. DOI: 10.1016/j.ymthe.2003.12.001. View

Dwyer R, Bergert E, OConnor M, Gendler S, Morris J . Adenovirus-mediated and targeted expression of the sodium-iodide symporter permits in vivo radioiodide imaging and therapy of pancreatic tumors. Hum Gene Ther. 2006; 17(6):661-8. DOI: 10.1089/hum.2006.17.661. View

Anton M, Wagner B, Haubner R, Bodenstein C, Essien B, Bonisch H . Use of the norepinephrine transporter as a reporter gene for non-invasive imaging of genetically modified cells. J Gene Med. 2004; 6(1):119-26. DOI: 10.1002/jgm.472. View

Carlson S, Classic K, Hadac E, Dingli D, Bender C, Kemp B . Quantitative molecular imaging of viral therapy for pancreatic cancer using an engineered measles virus expressing the sodium-iodide symporter reporter gene. AJR Am J Roentgenol. 2008; 192(1):279-87. PMC: 2710889. DOI: 10.2214/AJR.08.1205. View

Mandell R, Mandell L, Link Jr C . Radioisotope concentrator gene therapy using the sodium/iodide symporter gene. Cancer Res. 1999; 59(3):661-8. View

10.

Luker G, Luker K . Optical imaging: current applications and future directions. J Nucl Med. 2007; 49(1):1-4. DOI: 10.2967/jnumed.107.045799. View

11.

Hays M, Berman M . Pertechnetate distribution in man after intravenous infusion: a compartmental model. J Nucl Med. 1977; 18(9):898-904. View

12.

Faivre J, Clerc J, Gerolami R, Herve J, Longuet M, Liu B . Long-term radioiodine retention and regression of liver cancer after sodium iodide symporter gene transfer in wistar rats. Cancer Res. 2004; 64(21):8045-51. DOI: 10.1158/0008-5472.CAN-04-0893. View

13.

Vadysirisack D, Shen D, Jhiang S . Correlation of Na+/I- symporter expression and activity: implications of Na+/I- symporter as an imaging reporter gene. J Nucl Med. 2006; 47(1):182-90. View

14.

Mitrofanova E, Unfer R, Vahanian N, Link C . Rat sodium iodide symporter allows using lower dose of 131I for cancer therapy. Gene Ther. 2006; 13(13):1052-6. DOI: 10.1038/sj.gt.3302758. View

15.

Barton K, Stricker H, Brown S, Elshaikh M, Aref I, Lu M . Phase I study of noninvasive imaging of adenovirus-mediated gene expression in the human prostate. Mol Ther. 2008; 16(10):1761-9. PMC: 3127288. DOI: 10.1038/mt.2008.172. View

16.

Peerlinck I, Merron A, Baril P, Conchon S, Martin-Duque P, Hindorf C . Targeted radionuclide therapy using a Wnt-targeted replicating adenovirus encoding the Na/I symporter. Clin Cancer Res. 2009; 15(21):6595-601. DOI: 10.1158/1078-0432.CCR-09-0262. View

17.

Hasegawa K, Pham L, OConnor M, Federspiel M, Russell S, Peng K . Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter. Clin Cancer Res. 2006; 12(6):1868-75. DOI: 10.1158/1078-0432.CCR-05-1803. View

18.

Spitzweg C, Morris J . Genetics and phenomics of hypothyroidism and goiter due to NIS mutations. Mol Cell Endocrinol. 2010; 322(1-2):56-63. PMC: 2876245. DOI: 10.1016/j.mce.2010.02.007. View

19.

Waerzeggers Y, Monfared P, Viel T, Winkeler A, Voges J, Jacobs A . Methods to monitor gene therapy with molecular imaging. Methods. 2009; 48(2):146-60. DOI: 10.1016/j.ymeth.2009.03.007. View

20.

Sharma V, Luker G, Piwnica-Worms D . Molecular imaging of gene expression and protein function in vivo with PET and SPECT. J Magn Reson Imaging. 2002; 16(4):336-51. DOI: 10.1002/jmri.10182. View